Seema Singhal

22.0k total citations · 1 hit paper
291 papers, 10.7k citations indexed

About

Seema Singhal is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Seema Singhal has authored 291 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Hematology, 97 papers in Oncology and 67 papers in Molecular Biology. Recurrent topics in Seema Singhal's work include Multiple Myeloma Research and Treatments (103 papers), Hematopoietic Stem Cell Transplantation (74 papers) and Acute Myeloid Leukemia Research (35 papers). Seema Singhal is often cited by papers focused on Multiple Myeloma Research and Treatments (103 papers), Hematopoietic Stem Cell Transplantation (74 papers) and Acute Myeloid Leukemia Research (35 papers). Seema Singhal collaborates with scholars based in United States, United Kingdom and India. Seema Singhal's co-authors include Jayesh Mehta, Bart Barlogie, David S. Siegel, Nikhil C. Munshi, R Powles, C Horton, Jerome B. Zeldis, John Crowley, Madhav V. Dhodapkar and Raman Desikan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Seema Singhal

272 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

1999 2.0k citations Seema Singhal, Jayesh Mehta et al. profile →

Peers

Countries citing papers authored by Seema Singhal

Since Specialization

Citations

This map shows the geographic impact of Seema Singhal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seema Singhal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seema Singhal more than expected).

Fields of papers citing papers by Seema Singhal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seema Singhal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seema Singhal. The network helps show where Seema Singhal may publish in the future.

Co-authorship network of co-authors of Seema Singhal

This figure shows the co-authorship network connecting the top 25 collaborators of Seema Singhal. A scholar is included among the top collaborators of Seema Singhal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seema Singhal. Seema Singhal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cachexia in gynecologic cancers: The role of biomarkers and cachexia index 2025 ·International Journal of Gynecology & Obstetrics ·(unknown), Ekta Dhamija, Neena Malhotra, (unknown), Archana Singh, Seema Singhal	0
2	The serum levels of leptin and adiponectin in endometrial carcinoma and their association with histopathological factors 2025 ·Journal of Cancer Research and Therapeutics ·(unknown), (unknown), Daya Nand Sharma, Rajesh Khadgawat, Lalit Kumar, Perumal Vanamail, Jyoti Meena, Seema Singhal	0
3	The beginning of the end for cervical cancer in India 2024 ·International Journal of Gynecological Cancer ·(unknown), Seema Singhal	1
4	Patterns of care for vulvar cancer and insights from revised FIGO staging: a retrospective study 2024 ·World Journal of Surgical Oncology ·Seema Singhal, (unknown), Sandeep Mathur, (unknown), Jyoti Meena, (unknown), Neerja Bhatla	1
5	2022-RA-1602-ESGO Cutaneous metastasis in epithelial ovarian cancer: experience from a tertiary care cancer institute 2022 ·International Journal of Gynecological Cancer ·(unknown), Seema Singhal, Neerja Bhatla, Jyoti Meena, (unknown), Rajesh Kumari, (unknown)	1
6	Continuous Glucose Monitoring System Profile of Women with Gestational Diabetes Mellitus Missed Using Isolated Fasting Plasma Glucose-Based Strategies Alternative to WHO 2013 Criteria: A Cross-Sectional Study 2022 ·Diabetes Therapy ·Yashdeep Gupta, Charandeep Singh, Alpesh Goyal, Mani Kalaivani, (unknown), Seema Singhal, Garima Kachhawa, Vidushi Kulshrestha, Rajesh Kumari, Reeta Mahey, Jai Bhagwan Sharma, Neena Malhotra, Neerja Bhatla, Rajesh Khadgawat, Nikhil Tandon	2
7	Continuous glucose monitoring system profile of women diagnosed as gestational diabetes mellitus by International Association of Diabetes and Pregnancy Study Groups criteria and labeled as normoglycemic by alternate criteria in early pregnancy 2022 ·Journal of Diabetes Investigation ·Yashdeep Gupta, Charandeep Singh, Alpesh Goyal, Mani Kalaivani, (unknown), Seema Singhal, Garima Kachhawa, Vidushi Kulshrestha, Rajesh Kumari, Reeta Mahey, Jai Bhagwan Sharma, Neena Malhotra, Neerja Bhatla, Rajesh Khadgawat, Nikhil Tandon	10
8	A Cross-Sectional Analysis to Evaluate Knowledge, Attitude And Practices Among Pregnant Women During COVID-19 Pandemic 2021 ·The Journal of Obstetrics and Gynecology of India ·(unknown), (unknown), Perumal Vanamail, Aparna Sharma, Vatsla Dadhwal, Vidushi Kulshrestha, Seema Singhal, Jyoti Meena, Sunesh Kumar, Neerja Bhatla	14
9	High burden of cardiometabolic risk factors in spouses of Indian women with hyperglycaemia in pregnancy 2020 ·Diabetic Medicine ·Yashdeep Gupta, Alpesh Goyal, Mani Kalaivani, Seema Singhal, Neerja Bhatla, Noopur Gupta, Nikhil Tandon	7
10	SHORT TERM USE OF INJECTABLE DMPA FOR CONTRACEPTION IN IMMEDIATE POSTPARTUM WOMEN 2017 ·Seema Singhal, (unknown), (unknown), (unknown)	1
11	A prospective randomized study comparing unipolar versus bipolar hysteroscopic myomectomy in infertile women 2017 ·Journal of Human Reproductive Sciences ·(unknown), (unknown), (unknown), Sunesh Kumar, Seema Singhal, Perumal Vanamail	13
12	Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin 2014 ·Clinical Cancer Research ·(unknown), Richa Bajpai, (unknown), Kehinde Adekola, Irawati Kandela, Changyong Wei, Seema Singhal, Jennifer E. Koblinski, Noopur Raje, Steven T. Rosen, Mala Shanmugam	123
13	Clinical profile & outcome of H1N1 infected pregnant women in a tertiary care teaching hospital of northern India 2014 ·SHILAP Revista de lepidopterología ·Seema Singhal, (unknown), (unknown), (unknown), Anil Jain	5
14	Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma? 2008 ·Bone Marrow Transplantation ·(unknown), Jairam Krishnamurthy, (unknown), Richard Meagher, (unknown), (unknown), Andrew M. Evens, Olga Frankfurt, Jessica K. Altman, Leo I. Gordon, Martin S. Tallman, Stephanie Williams, Jane N. Winter, Seema Singhal, Jayesh Mehta	5
15	How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients? 2004 ·Bone Marrow Transplantation ·Amit Verma, (unknown), Steven Trifilio, Seema Singhal, Martin S. Tallman, Jane N. Winter, Stephanie Williams, Leo I. Gordon, (unknown), Jayesh Mehta	4
16	Recent Developments and Future Directions in the Treatment of Multiple Myeloma 2003 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Seema Singhal, Jayesh Mehta, Steven T. Rosen	2
17	Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial 2000 ·The Lancet ·R Powles, Jayesh Mehta, Samar Kulkarni, J Treleaven, Barbara C. Millar, (unknown), V Shepherd, A. J. Rowland, Bhawna Sirohi, Diana Tait, C Horton, S. G. Long, Seema Singhal	268
18	A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold? 2000 ·Bone Marrow Transplantation ·Seema Singhal, R Powles, J Treleaven, S Kulkarni, Bhawna Sirohi, C Horton, B. C. Millar, V Shepherd, Diana Tait, Radovan Sašo, A. J. Rowland, S. G. Long, Jayesh Mehta	85
19	Second cancers after non-autologous bone marrow transplantation for hematologic malignancies 1998 ·British Journal of Haematology ·(unknown), R Powles, Seema Singhal, Minesh P. Mehta, J Treleaven, C Horton, (unknown), CR Pinkerton, Ayad Atra, Diana Tait	1
20	Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignancies 1997 ·Journal of Clinical Apheresis ·Jayesh Mehta, R Powles, Jennie Treleaven, Barbara C. Millar, (unknown), Sandra Cabral, V Shepherd, Seema Singhal	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact